IMPACT OF TIMING FROM BLOOD SAMPLING TO PHARMACODYNAMIC ASSESSMENT ON MEASURES OF PLATELET REACTIVITY IN PATIENTS TREATED WITH P2Y12 RECEPTOR INHIBITORS

Conclusions In patients on maintenance therapy with P2Y12 inhibitors, timing from blood sampling to processing significantly influences PD measures as assessed by VN and LTA, but not by VASP.

Saved in:
Bibliographic Details
Published inJournal of the American College of Cardiology Vol. 67; no. 13; p. 214
Main Authors Rollini, Fabiana, Franchi, Francesco, Singh, Kamaldeep, Cho, Jung Rae, Bhatti, Mona, DeGroat, Christopher, Hu, Jenny, Aggarwal, Niti, Alobaidi, Zeina, Thano, Estela, Ferrante, Elisabetta, Zenni, Martin, Bass, Theodore, Angiolillo, Dominick
Format Journal Article
LanguageEnglish
Published New York Elsevier Inc 05.04.2016
Elsevier Limited
Subjects
Cardiology
Cardiovascular
Internal Medicine
Online AccessGet full text

Cover

More Information
Summary:Conclusions In patients on maintenance therapy with P2Y12 inhibitors, timing from blood sampling to processing significantly influences PD measures as assessed by VN and LTA, but not by VASP.
ISSN:0735-1097
1558-3597
DOI:10.1016/S0735-1097(16)30215-7